Fetalix participated in the RESOLVE-Health Living Labs programme, developed in partnership with OneVet, under the call “Innovations in Animal Health Living Lab”, supporting early-stage market validation activities for the company’s emerging solution targeting canine low back pain.
Understanding the needs and perspectives of both veterinary professionals and pet owners is an important step in the development and validation of new animal health technologies. Programmes such as RESOLVE-Health Living Labs create opportunities for early interaction with end users, supporting the assessment of clinical relevance, market potential, and adoption challenges for emerging solutions.
RESOLVE-Health 2.0 is an acceleration programme focused on supporting seed projects and startups in the health sector, fostering the translation of scientific knowledge and innovative ideas into sustainable business ventures and value creation. Through its Living Labs initiative, the programme supports the development and validation of new technologies, therapies, and solutions addressing animal health challenges.
Through the programme, Fetalix established a collaboration with Luís Lobo from OneVet, enabling the preparation and distribution of surveys directed to veterinarians and dog owners. The initiative aimed to gather insights regarding the perception and potential acceptance of Fetalix’s emerging solution for canine low back pain, contributing valuable feedback for the continued development and validation of the technology.
July 30, 2023
